Nicotine cue study using propranolol to study craving
Treatments studied
Part of Mental health clinical trials.
This study tests whether a beta-blocking medicine (propranolol) and nicotine patches change how strongly your brain responds to smoking cues. It may help researchers understand what drives cigarette cravings and how to reduce them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 21 to 60
- Smoke at least 5 cigarettes per day every day for at least 1 year, with stable smoking for the last 6 months
- Have proof of smoking in your tests (expired carbon monoxide of 6+ ppm and/or a urine nicotine level above 100 ng/mL)
- Be able to attend all study visits and complete required tasks
- Use English well enough to read and understand study materials
- Be right-handed (per a short set of questions)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how your brain reacts to smoking cues after using an oral nicotine pouch. You would need to try the pouch and avoid nicotine for 12 hours before each session.
This study looks at how a brain system called orexin may affect nicotine addiction. If you smoke regularly and meet diagnostic criteria, the trial may help researchers understand what brain changes could improve nicotine dependence.
This trial tests if a type of brain stimulation (TMS) can help people with nicotine dependence reduce cravings. It may be an option if you smoke or use e-cigarettes heavily and want to understand how your brain responds to treatment.
This trial tests whether combining brain stimulation (tDCS) with a smoking cessation medication (varenicline) helps people quit smoking. You would attend daily visits for two weeks.
This study compares how your body and mind respond to your usual menthol cigarettes versus a new menthol cigarette. Researchers want to understand how different menthol cigarettes affect smoking behavior and cravings over two weeks.
This study tests how a medicine called cytisinicline (similar to a plant-based stop-smoking aid) affects brain activity when you see or think about smoking. It may help researchers understand how the medicine works, even if you aren't ready to quit right now.
Hear when a new Tobacco Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.